As discussed above, endogenous GLP-1 is rapidly degraded by DPP-4, whereby it loses its insulinotropic activity, and preventing this degradation results in increased intact GLP-1 levels, improved pancreatic islet responses (enhanced insulin and suppressed glucagon levels) and beneficial effects on glucose homeostasis
Quick Answer: GLP-1 receptor agonists show preliminary promise in reducing binge eating episodes, but are not currently licensed for binge eating disorder in the UK and require further research
This is another advantage of establishing relationships with reputable, experienced suppliers rather than chasing the lowest price from unknown sources
This form promotes nitric oxide production
The researchers compared breast cancer survival for GLP-1 drugs with that of current diabetes therapies
TB-500 nasal spray formulation offers an alternative to injections and provides a convenient and research-friendly approach to delivering the benefits of TB-500